3,138 Shares in Colgate-Palmolive Company $CL Purchased by Precision Wealth Strategies LLC

Precision Wealth Strategies LLC bought a new position in Colgate-Palmolive Company (NYSE:CL) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 3,138 shares of the company’s stock, valued at approximately $285,000.

A number of other hedge funds also recently made changes to their positions in the company. Trust Co. of Vermont lifted its position in shares of Colgate-Palmolive by 3.5% in the second quarter. Trust Co. of Vermont now owns 21,345 shares of the company’s stock worth $1,940,000 after buying an additional 725 shares in the last quarter. Pacific Point Advisors LLC lifted its position in shares of Colgate-Palmolive by 5.1% in the second quarter. Pacific Point Advisors LLC now owns 17,076 shares of the company’s stock worth $1,552,000 after buying an additional 829 shares in the last quarter. Childress Capital Advisors LLC lifted its position in shares of Colgate-Palmolive by 54.1% in the second quarter. Childress Capital Advisors LLC now owns 3,411 shares of the company’s stock worth $310,000 after buying an additional 1,197 shares in the last quarter. PFG Investments LLC lifted its position in shares of Colgate-Palmolive by 4.4% in the second quarter. PFG Investments LLC now owns 23,119 shares of the company’s stock worth $2,101,000 after buying an additional 965 shares in the last quarter. Finally, Bennett Selby Investments LP raised its position in Colgate-Palmolive by 41.8% during the second quarter. Bennett Selby Investments LP now owns 5,830 shares of the company’s stock valued at $530,000 after purchasing an additional 1,718 shares during the period. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. Barclays decreased their price objective on Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating on the stock in a research report on Wednesday. Morgan Stanley decreased their price objective on Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. The Goldman Sachs Group decreased their price objective on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a research report on Thursday. UBS Group decreased their price objective on Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating on the stock in a research report on Thursday, July 17th. Finally, Wells Fargo & Company decreased their price objective on Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating on the stock in a research report on Thursday, September 25th. Eight investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus target price of $96.75.

Colgate-Palmolive Trading Down 0.9%

Shares of NYSE CL opened at $78.30 on Friday. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The business’s 50 day moving average price is $83.49 and its 200-day moving average price is $88.41. Colgate-Palmolive Company has a fifty-two week low of $78.18 and a fifty-two week high of $102.61. The company has a market cap of $63.28 billion, a price-to-earnings ratio of 21.99, a PEG ratio of 4.11 and a beta of 0.34.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The firm had revenue of $5.11 billion for the quarter, compared to the consensus estimate of $5.03 billion. During the same period in the prior year, the business posted $0.91 earnings per share. The company’s revenue for the quarter was up 1.0% on a year-over-year basis. On average, sell-side analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.7%. Colgate-Palmolive’s dividend payout ratio is 58.43%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.